RLAY EBITDA Growth
Relay Therapeutics Inc · EBITDA Growth
RLAY EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported7.44%period ending
RLAY TTM EBITDA YoY % (36.01% → 7.44%)
Year-over-year change
High-resolution chart · PNG
RLAY ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 7.4394% | |
| 22.4626% | |
| 24.8089% | |
| 23.0563% | |
| 16.6439% | |
| 4.38% | |
| 2.9886% | |
| -4.868% | |
| 1.0256% | |
| -6.591% | |
| -21.9446% | |
| -25.5393% | |
| -39.7666% | |
| -38.2238% | |
| -38.0949% | |
| -139.2132% | |
| -169.2741% | |
| -264.1143% | |
| -327.6102% | |
| -6.9957% | |
| -0.0507% | |
| 25.4988% | |
| 36.0134% |